Inventor

GENDRON ROLAND

US76 patents

⚠️ This page may combine multiple inventors who share the name “GENDRON ROLAND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

THERAVANCE INC

18 patents

US7879896B2Feb 1, 2011

Dual-acting imidazole antihypertensive agents

THERAVANCE INC53 citations98

US8013005B2Sep 6, 2011

Dual-acting antihypertensive agents

THERAVANCE INC42 citations96

US8846913B2Sep 30, 2014

Neprilysin inhibitors

THERAVANCE INC18 citations93

US8377964B2Feb 19, 2013

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC10 citations93

US7759363B2Jul 20, 2010

Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists

THERAVANCE INC18 citations93

US7317022B2Jan 8, 2008

Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists

THERAVANCE INC19 citations93

US7989484B2Aug 2, 2011

Dual-acting antihypertensive agents

THERAVANCE INC25 citations92

US7956054B2Jun 7, 2011

Dual-acting pyrazole antihypertensive agents

THERAVANCE INC21 citations92

US7863309B2Jan 4, 2011

Dual-acting antihypertensive agents

THERAVANCE INC27 citations92

US7834041B2Nov 16, 2010

Dual-acting antihypertensive agents

THERAVANCE INC29 citations92

US7419989B2Sep 2, 2008

Indazole-carboxamide compounds

THERAVANCE INC19 citations92

US7396933B2Jul 8, 2008

Quinolinone-carboxamide compounds

THERAVANCE INC28 citations92

US7351704B2Apr 1, 2008

Indazole-carboxamide compounds as 5-HT4 receptor agonists

THERAVANCE INC25 citations92

US7498442B2Mar 3, 2009

Quinolinone-carboxamide compounds

THERAVANCE INC10 citations84

US7446114B2Nov 4, 2008

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC10 citations84

US8344013B2Jan 1, 2013

Dual-acting imidazole antihypertensive agents

THERAVANCE INC4 citations74

US7875629B2Jan 25, 2011

Quinolinone compounds as 5-HT4 receptor agonists

THERAVANCE INC6 citations74

US8349875B2Jan 8, 2013

Dual-acting antihypertensive agents

THERAVANCE INC3 citations73

THERAVANCE BIOPHARMA R&D IP LLC

11 patents

US10759813B2Sep 1, 2020

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84

US10336773B2Jul 2, 2019

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC5 citations84

US10123984B2Nov 13, 2018

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC3 citations84

US9845332B2Dec 19, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC7 citations84

US9688692B2Jun 27, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC7 citations84

US11261197B2Mar 1, 2022

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC1 citations73

US10744104B2Aug 18, 2020

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC2 citations73

US9771337B2Sep 26, 2017

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC2 citations73

US12016835B2Jun 25, 2024

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations63

US11851443B2Dec 26, 2023

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations63

US11547687B2Jan 10, 2023

Neprilysin inhibitors

THERAVANCE BIOPHARMA R&D IP LLC0 citations63

FLEURY MELISSA

5 patents

US8481044B2Jul 9, 2013

Neprilysin inhibitors

FLEURY MELISSA67 citations98

US8449890B2May 28, 2013

Neprilysin inhibitors

FLEURY MELISSA68 citations98

US8686184B2Apr 1, 2014

Neprilysin inhibitors

FLEURY MELISSA61 citations97

US9499487B2Nov 22, 2016

Neprilysin inhibitors

FLEURY MELISSA12 citations84

US9334245B2May 10, 2016

Neprilysin inhibitors

FLEURY MELISSA3 citations73

GENDRON ROLAND

4 patents

US8586536B2Nov 19, 2013

Neprilysin inhibitors

GENDRON ROLAND72 citations98

US8513244B2Aug 20, 2013

Neprilysin inhibitors

GENDRON ROLAND79 citations98

US9120747B2Sep 1, 2015

Neprilysin inhibitors

GENDRON ROLAND16 citations92

US9388145B2Jul 12, 2016

Neprilysin inhibitors

GENDRON ROLAND8 citations84

ALLEGRETTI PAUL

4 patents

US8158659B2Apr 17, 2012

Dual-acting imidazole antihypertensive agents

ALLEGRETTI PAUL11 citations92

US8895755B2Nov 25, 2014

Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity

ALLEGRETTI PAUL3 citations73

US8569351B2Oct 29, 2013

Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity

ALLEGRETTI PAUL3 citations73

US8236846B2Aug 7, 2012

Dual-acting antihypertensive agents

ALLEGRETTI PAUL5 citations73

HUGHES ADAM D

3 patents

US8691868B2Apr 8, 2014

Neprilysin inhibitors

HUGHES ADAM D57 citations98

US9682052B2Jun 20, 2017

Neprilysin inhibitors

HUGHES ADAM D4 citations84

US9150500B2Oct 6, 2015

Neprilysin inhibitors

HUGHES ADAM D5 citations84

SMITH CAMERON

2 patents

US8563512B2Oct 22, 2013

Neprilysin inhibitors

SMITH CAMERON62 citations97

US9555041B2Jan 31, 2017

Neprilysin inhibitors

SMITH CAMERON2 citations72

CHOI SEOK-KI

2 patents

US9012485B2Apr 21, 2015

Dual-acting imidazole antihypertensive agents

CHOI SEOK-KI2 citations73

US8080572B2Dec 20, 2011

Dual-acting antihypertensive agents

CHOI SEOK-KI5 citations73

BLAIR BROOKE

1 patent

US8119634B2Feb 21, 2012

Dual-acting pyrazole antihypertensive agents

BLAIR BROOKE6 citations81

Showing the top 50 of 76 patents by PatentIndex Score.